Hypothalamic Dysfunction

Carlo Gabriel Casipit; Catherine Anastasopoulou

Hypothalamic Dysfunction

Author: Carlo Gabriel Casipit Editor: Catherine Anastasopoulou Updated: 3/23/2026 1:58:03 AM

Introduction

The hypothalamus is a part of the diencephalon composed of several small nuclei with distinct physiologic functions. One of the main functions of the hypothalamus is to maintain homeostasis by regulating endocrine and autonomic functions; nevertheless, the hypothalamus also participates in other functions, eg, body temperature regulation, appetite and weight control, childbirth, growth, breast milk production, the sleep-wake cycle, sex drive, emotions, and behavior. A disorder of the hypothalamus can cause different signs and symptoms, depending on the particular affected area. Clinical manifestations vary, depending on the affected hypothalamic nuclei and their functions. Certain signs and symptoms can be traced to specific anatomic areas due to the functional organization of the hypothalamus.[1]

Anatomically, this structure can be organized in the sagittal plane into 3 main regions: the anterior, the middle, and the posterior hypothalamus. Each main region contains hypothalamic nuclei that serve different physiologic functions. The anterior region contains 5 nuclei: preoptic, paraventricular, supraoptic, suprachiasmatic, and anterior hypothalamic nucleus. The middle region is situated directly above the tuber cinereum and the infundibulum and contains 3 nuclei: the arcuate nucleus, ventromedial nucleus, and dorsomedial nucleus. The posterior region contains the posterior hypothalamic nucleus and the mammillary nucleus in the mammillary bodies.

Anterior Region

The anterior structures of the hypothalamus include:

Preoptic nucleus: The primary function of the preoptic nucleus is the production and secretion of gonadotropin-releasing hormone (GnRH) for sex hormone regulation. GnRH is released into the tuberoinfundibular tract and is transported through the hypophyseal portal system to the adenohypophysis. This nucleus also participates in initiating nonrapid eye movement sleep by inhibiting histaminergic neurons in the hypothalamus and cholinergic and noradrenergic neurons in the brainstem. The preoptic nucleus is also involved in thermoregulation.

Paraventricular nucleus: This structure participates in the production and secretion of several hormones, predominantly oxytocin. The paraventricular nucleus also produces and secretes small amounts of vasopressin, known as antidiuretic hormone (ADH). Another hormone produced is a corticotropin-releasing hormone (CRH), which regulates adrenocorticotropic hormone (ACTH) secretion by the anterior pituitary. The paraventricular nucleus also produces thyroid-releasing hormone (TRH), which regulates thyroid-stimulating hormone (TSH) secretion by the anterior pituitary, which ultimately controls peripheral thyroid hormone secretion. This nucleus contains glutamate and AngII-releasing neurons, which induce sympatho-excitatory effects, whereas gamma-aminobutyric acid and nitric oxide-releasing neurons induce sympatho-inhibitory effects. These sympathetic effects, when deregulated, contribute to heart failure.[2]

Supraoptic nucleus: The secretory functions of the supraoptic nucleus are similar to the paraventricular nucleus, but its primary function is the production and secretion of vasopressin. This nucleus also produces and secretes oxytocin to a lesser degree than the paraventricular nucleus.

Suprachiasmatic nucleus: The suprachiasmatic nucleus receives direct input from retinal ganglion cells and synchronizes body functions with periods of light and dark to a circadian rhythm. This structure projects to the pineal gland, which secretes the hormone melatonin, a sleep-inducing hormone.

Anterior hypothalamic nucleus: Body temperature is controlled by the anterior hypothalamic nucleus, including cooling or reducing body temperature.

Middle Region

The middle structures of the hypothalamus include:

Arcuate nucleus: Growth hormone-releasing hormone (GHRH) is released by the arcuate nucleus, and this structure also produces prolactin-inhibiting hormone (dopamine).

Ventromedial nucleus: This is the center of satiety or fullness, as well as regulating appetite and weight control.

Dorsomedial nucleus: This structure is an emotional response center. Stimulation of the dorsomedial nucleus in animal experiments produced aggressive behavior that lasted only as long as the stimulus was applied. The dorsomedial nucleus is also involved with blood pressure, heart rate, and gastrointestinal stimulation.

Posterior Region

The posterior structures of the hypothalamus include:

Mammillary nucleus: The mammillary nucleus is part of the limbic system, which is responsible for memory, behavior, and motivation. Degeneration of this nucleus classically occurs in Korsakoff syndrome.[3][4] This structure is involved in memory, emotion regulation, and heart dysfunction.

Posterior hypothalamic nucleus: This structure participates in blood pressure regulation, pupillary dilation, and thermoregulation, particularly body temperature conservation, eg, shivering when a person is cold.

The hypothalamus serves multiple physiologic functions that indirectly affect almost all organs in the body. However, the hypothalamus is primarily responsible for the following:

Hormonal regulation
Autonomic responses
Essential day-to-day physiologic functions, eg, thermoregulation, circadian rhythm, hunger and appetite, sexual behaviors, and emotional and behavioral responses)

Hormonal regulation

The hypothalamus produces the following releasing and inhibitory hormones that travel via the hypophyseal portal system to the anterior pituitary, regulating its secretion of tropic hormones that control the activity of most peripheral endocrine glands:

GnRH: Stimulates the anterior pituitary to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH) that regulate the reproductive function

CRH: Stimulates ACTH release from the pituitary, which is essential for the stress response

TRH: Stimulates TSH secretion that ultimately influences the metabolic activity

GHRH: Stimulates growth hormone release that is important for growth and metabolic regulation

Somatostatin: Inhibits the secretion of growth hormone and TSH from the pituitary

Dopamine: Acts as the primary prolactin-inhibiting hormone

Oxytocin: Produced by hypothalamic neurons; involved in uterine contractions during labor and milk ejection during lactation

Vasopressin (antidiuretic hormone [ADH]): Regulates water balance and contributes to blood pressure control

Autonomic regulation

The hypothalamus influences the autonomic nervous system by regulating autonomic output through the integration of signals from autonomic centers within the brainstem and spinal cord, thereby modulating parasympathetic and sympathetic signals and ultimately influencing vital homeostatic functions, eg, blood pressure, heart rate, respiratory pattern, and digestion.

Essential Physiologic Responses

Thermoregulation

The preoptic nuclei of the anterior hypothalamus sense increased body temperature and promote heat loss via sweating and vasodilation. Whereas the posterior hypothalamus is activated by cold temperatures, facilitating heat-conserving mechanisms through shivering and blood vessel vasoconstriction. Both mechanisms ensure a near-constant body temperature, which is essential for optimal bodily functions.

Circadian rhythm

The suprachiasmatic nucleus of the hypothalamus receives input from the retina and processes this information to synchronize the body's sleep-wake cycle and is secondarily responsible for the diurnal variation of hormonal secretion.

Hunger and appetite regulation

The lateral hypothalamic nuclei produce orexigenic signals stimulating feeding behavior and appetite. On the other hand, the ventromedial nucleus functions as the satiety center, causing meal termination, while the arcuate nucleus detects hormonal signals, including insulin, ghrelin, and leptin, coordinating physiologic responses between the lateral and ventromedial hypothalamus in response to appetite and satiety.

Sexual behavior and fertility

The hypothalamus is essential to sexual function by producing hormonal signals to the pituitary, which in turn triggers gonadal hormone secretion. In addition, because the hypothalamus is closely linked to the limbic system, it can integrate sensory input, eg, visual, tactile, and olfactory cues, to modulate sexual behaviors. Lastly, the hypothalamus is able to coordinate autonomic output to cause erection, vaginal lubrication, and ejaculation.

Emotional and behavioral response

The hypothalamus is anatomically and functionally connected to the limbic system, a vast neuronal network that primarily regulates emotion, behavior, and motivation. The hypothalamus also receives inputs from the limbic system, integrates them, and sends coordinated endocrine and autonomic output to produce behavioral and emotional responses.

Etiology

Register For Free And Read The Full Article

Get the answers you need instantly with the StatPearls Clinical Decision Support tool. StatPearls spent the last decade developing the largest and most updated Point-of Care resource ever developed. Earn CME/CE by searching and reading articles.

Search engine and full access to all medical articles
10 free questions in your specialty
Free CME/CE Activities

Free daily question in your email
Save favorite articles to your dashboard
Emails offering discounts

Learn more about a Subscription to StatPearls Point-of-Care

Etiology

Hypothalamic dysfunction has numerous underlying etiologies, including:

Brain surgery [5][6][7]
Traumatic brain injury [8][9][10]
Brain tumors, including pituitary lesions [11][12][13][14][15]
Radiation [16][17]
Cancer and Chemotherapy [18][19][20][21][22]
Nutritional deficiencies (anorexia nervosa) [23]
Brain aneurysms [24][25]
Genetic disorders (Prader-Willi syndrome, Kallmann syndrome) [26][27][28][29]
Infections [30][31]
Inflammatory diseases (multiple sclerosis, neurosarcoidosis) [32][33]
Paraneoplastic syndromes [34]
Rapid-onset obesity with hypothalamic dysfunction, hypoventilation, and autonomic dysregulation syndrome [35][36]

Epidemiology

The epidemiology of hypothalamic dysfunction depends on the patient's clinical presentation and etiology. Hypothalamic dysfunction accounts for almost 20% to 35% of the cases of secondary amenorrhea in the United States.[37] Pediatric cancer survivors may present a prevalence of 40.2% of hypothalamic-pituitary dysfunction, predominantly for growth hormone.[19][21] Traumatic brain injury in children may increase their risk for developing central endocrine dysfunction 3 times compared to the general population.[38] In children with hypothalamic dysfunction, girls have a 2:1 predominance. In the general population with traumatic brain injury, the incidence of hypopituitarism has been reported in the range of 11% to 80%.[39][40][41]

Pathophysiology

The hypothalamus, as previously discussed, is responsible for hormonal regulation, autonomic responses, and essential day-to-day physiologic functions, eg, thermoregulation, circadian rhythm, hunger and appetite control, sexual behaviors, and emotional and behavioral responses. Hypothalamic dysfunction refers to the inability of the hypothalamus to carry out these vital physiologic and regulatory functions.[42]

Hypothalamic dysfunction can occur through the following 3 main mechanisms:

Direct damage to hypothalamic nuclei
Disruption of hypothalamic control over pituitary hormonal production, resulting in hormone hyposecretion
Termination of vital hypothalamic neuronal circuits to autonomic and limbic centers, affecting physiologic functions as well as emotional and behavioral responses

Direct injury to the preoptic nuclei, which regulate heat-loss mechanisms, can result in hyperthermia, while damage to the posterior hypothalamus, responsible for heat conservation, may produce hypothermia. Insults to the suprachiasmatic nucleus can disturb circadian rhythm, disrupting sleep-wake cycles and diurnal hormonal patterns. Lesions of the ventromedial nucleus, which functions as the satiety center, can provoke hyperphagia and subsequent weight gain, whereas injury to the lateral hypothalamus, the hunger center, can induce anorexia and weight loss.[43] Damage to the mammillary bodies, which play a critical role in memory consolidation, may lead to anterograde amnesia, impairing the ability to form new memories.

Hypothalamic dysfunction can lead to disruption of its hormonal regulatory function to the pituitary, causing hormonal hyposecretion and downstream central hypothyroidism, secondary adrenal insufficiency, secondary hypogonadism and infertility, and diabetes insipidus. Hypothalamic dysfunction can also disrupt dopaminergic pathways, leading to prolactin disinhibition and hyperprolactinemia.

Disruption of hypothalamic autonomic output can impair temperature regulation, cause blood pressure lability, and alter heart rate responses to pathophysiologic stressors. Subsequently, disruption of its limbic system connections can cause emotional and behavioral changes, including but not limited to depression, anxiety, and aggressive behaviors.

Although there was initially a thought of age related changes in the hypothalamus structure, a new study showed no decline in the hypothalamus function in older age apart from the effect of the general risk factors on the expected function of the hypothalamic-pituitary-adrenal (HPA) axis.[44]

History and Physical

The hypothalamus has widespread physiologic functions that influence endocrine, autonomic, metabolic, emotional, and behavioral responses. Therefore, hypothalamic dysfunction often presents with overlapping and nonspecific symptoms.[45] A systematic evaluation, starting with a detailed history, a thorough review of systems, and a comprehensive physical examination, is warranted.

Clinical History

A detailed history is warranted with particular attention to the following components:

Symptom review: should include symptom onset, severity, quality, triggering, and relieving factors

General symptoms: weakness, fatigue, cognitive function, and sleep changes

Metabolic: appetite, weight gain, or weight loss

Endocrine: temperature intolerance, gynecomastia, decreased libido, infertility, galactorrhea, polydipsia, polyuria

Autonomic: palpitations, dizziness, syncope

Neurologic: headaches, visual changes, gaze problems, seizures, weakness, and sensory changes

Emotional and behavioral: emotional lability, anxiety, depression, aggression

Other comorbid conditions: particularly endocrine pathologies and a history of congenital diseases

Family history of endocrine disorders: particularly early-onset diseases

Medication review and exposures: steroids, hormonal treatments, chemoradiation

Prior surgeries [46]

Physical Examination

A thorough head-to-toe physical examination is essential, with particular attention to key endocrine findings, including:

Vital signs: temperature, heart rate, blood pressure, and, in some cases, orthostatic blood pressure

Anthropometrics: weight, height, BMI, and, in children, growth curves

Skin: rash, edema, striae, skin thickness, nail changes

Thyroid exam: goiter, nodules, agenesis

Visual and Neurologic evaluation: Glasgow coma scale, cranial nerve function, fundoscopic examination, motor and sensory function, reflexes, gait, balance, and coordination

Secondary sexual characteristics: hair distribution, particularly in the axillary and pubic areas, breast and testicular development, voice changes

Psychiatric behaviors: aggression and mood changes

Evaluation

In addition to a detailed history and comprehensive physical examination, a systematic laboratory evaluation and appropriate imaging studies are warranted to evaluate hypothalamic dysfunction.

Laboratory Evaluation

The following laboratory studies are recommended to evaluate hormonal deficiencies and their downstream effects with a focus on the hypothalamic–pituitary–target organ (HPO) axes:

Thyroid: TSH and free T4

Adrenal: Morning cortisol ± ACTH

Growth: IGF-1

Reproductive: LH, FSH, and estradiol or testosterone

Prolactin

Serum electrolytes, serum and urine osmolality, for suspected cases of diabetes insipidus or syndrome of inappropriate antidiuretic hormone (SIADH)

Dynamic endocrine testing may occasionally be necessary, as static hormonal measurements can at times be misleading (eg, the ACTH stimulation test, the insulin tolerance test, and the TRH stimulation test)

Diagnostic Imaging

The following imaging studies may be used to evaluate for structural causes:

Magnetic resonance imaging (MRI) of the brain with a dedicated hypothalamic–pituitary protocol

Computed tomography (CT) scan of the brain with and without contrast

End organ evaluation, eg, thyroid ultrasound, CT scan of the abdomen

Additional Studies

When indicated, further diagnostic studies may be indicated to evaluate symptom severity or complications, including the following:

Sleep studies

Visual field testing

Neuropsychiatric evaluation

Treatment / Management

Management of hypothalamic dysfunction is largely driven by its etiology and often involves regular endocrine monitoring, an interprofessional approach that addresses the underlying cause, supplements hormonal deficiencies, treats neurobehavioral symptoms, and controls autonomic and metabolic disturbances to optimize outcomes and quality of life.

Reversible hypothalamic suppression secondary to medication, significant weight loss, or excessive exercise is primarily corrected by managing the precipitating factors. Hypothalamic structural causes may often require surgery, chemoradiation, or immunosuppression with supportive hormonal supplementation.

Hypothalamic and downstream pituitary hormone deficiencies require long-term hormone replacement, which entails strict patient adherence, including levothyroxine for hypothyroidism, glucocorticoids for secondary adrenal insufficiency, sex hormone replacement for secondary hypogonadism, desmopressin for central diabetes insipidus, and, in selected cases, growth hormone for growth deficiency cases. In clinically significant hyperprolactinemia, a dopamine agonist is often warranted.

Symptomatic care includes supportive management of thermoregulation, heart rate, and blood pressure lability; proper sleep hygiene for sleep–wake disturbances, nutritional supplementation or correction for patients with metabolic dysfunction; and finally, cognitive and emotional support for mood and behavioral symptoms. Exercise has also been shown to improve obesity related to hypothalamic dysfunction by correcting inflammatory problems in the gland.[47]

Differential Diagnosis

Because the hypothalamus is responsible for a wide range of interconnected physiologic functions, many conditions, both endocrine and nonendocrine, can mimic or present with overlapping symptoms of hypothalamic dysfunction. Nonetheless, the differential diagnoses include:

Pituitary disorders: may present with similar hormonal deficiencies, and are influenced by hypothalamic regulation of pituitary hormone secretion

Primary endocrine disorders: can be differentiated from hypothalamic causes by characteristic laboratory patterns

Reversible hypothalamic suppression: due to excessive exercise (which is common in athletes) and rapid or significant weight loss

Primary psychiatric disorders: include primary eating disorders, mood and anxiety disorders, chronic fatigue syndrome, and somatic symptom disorders (these all may potentially affect appetite, sleep, emotion, and behavior)

Primary sleep disorders: eg, insomnia or hypersomnia, which are often easily neglected symptoms

Autonomic dysautonomia and neuropathy: can significantly cause blood pressure lability, inappropriate heart rate response to stressors, and problems with respiration and digestion.

Medication adverse effects

Prognosis

The prognosis of hypothalamic dysfunction varies heavily depending on its cause (idiopathic, trauma, congenital, tumor), extent, and the severity of hypothalamic damage. Nonetheless, prompt identification and early treatment promote improvement in the quality of life and lower rates of complications. Most hormonal deficiencies tend to respond well to hormonal replacement, effectively relieving symptoms, improving organ function, and preventing long-term metabolic complications.

Neurostructural lesions, requiring surgical interventions, often result in permanent hypothalamic dysfunction, requiring lifetime management and symptomatic hormonal replacement. Functional causes of hypothalamic dysfunction, such as significant weight loss and excessive exercise, generally have a good prognosis, often leading to complete recovery once the underlying trigger is corrected.

However, autonomic symptoms, eg, thermoregulatory instability and blood pressure lability, may be more difficult to control and can significantly affect quality of life. This may also be true of cognitive and behavioral changes, which may be only partially reversible, particularly with prolonged disease duration.

Complications

Because the hypothalamus regulates many essential functions, any form of hypothalamic dysfunction can impair them, leading to serious consequences. Hypothalamic dysfunction directly affects pituitary function, leading to secondary hormonal hyposecretion with crucial downstream consequences, including:

Central hypothyroidism, which can cause slowing of metabolic rate, hyperlipidemia, and cold intolerance
Secondary adrenal insufficiency, which can cause hypotension, electrolyte abnormalities, and, if severe, even death
Growth hormone deficiency, which can result in stunted growth in children and altered metabolism in adults
Hypogonadism, which can cause infertility and, in chronic cases, low bone mass
Prolactin disinhibition, which can cause loss of libido and infertility in both men and women, menstrual irregularities in females, and gynecomastia in men.
Because hypothalamic nuclei directly produce hormones, eg, ADH and oxytocin, damage to the hypothalamus can directly affect hormonal secretion from these nuclei, leading to central diabetes insipidus characterized by polydipsia, polyuria, and, in severe cases, dehydration.

Complications can also present as autonomic dysregulation, causing altered temperature regulation, labile blood pressure, and an inappropriate heart rate response to stressful situations. In addition, hypothalamic dysfunction can significantly affect day-to-day mood, emotions, and behavioral responses. In cases of hypothalamic mass or infiltrative conditions affecting the hypothalamus, neurologic consequences can include elevated intracranial pressure, visual gaze disturbances, and seizures.

Deterrence and Patient Education

Because of the chronic nature of hypothalamic dysfunction, not only the patient’s quality of life but also their caregivers' can be significantly impacted. Deterrents to care include, but are not limited to, poor understanding of their condition, medication noncompliance, and the overall cost of their care. Patient education for patients with hypothalamic dysfunction is of utmost importance, as empowered patients can more actively participate in their ongoing care.

Patient education should primarily focus on ensuring that the patient understands their condition and the chronic course of their disease, which often requires lifelong management and a long-term relationship with their doctors. Physicians should emphasize the importance of adherence to hormone replacement therapy, and patients should be taught to recognize underreplacement or overreplacement signs and symptoms and wear a medical alert identification bracelet for medical emergencies. Patients and caregivers should also be taught about the importance of nutrition, sleep, and mental coping mechanisms, especially in patients with mood and behavioral symptoms.

Enhancing Healthcare Team Outcomes

The hypothalamus is a central regulator of homeostasis, coordinating endocrine, autonomic, metabolic, and behavioral functions through its anatomically distinct anterior, middle, and posterior nuclei. It controls hormonal release via the pituitary, influences appetite, weight, thermoregulation, circadian rhythm, sexual function, and emotional behavior, and integrates autonomic responses critical to cardiovascular, gastrointestinal, and metabolic regulation. Dysfunction can arise from direct injury, disrupted hypothalamic–pituitary signaling, or impaired neural circuits, leading to hormone deficiencies, autonomic instability, metabolic disturbances, and neurobehavioral changes. Clinical presentations are often nonspecific, requiring careful history, focused physical examination, dynamic endocrine testing, and appropriate imaging for accurate diagnosis and management.

Effective care for patients with hypothalamic dysfunction relies on interprofessional collaboration and comprehensive skill sets. Physicians and advanced practitioners must assess and interpret endocrine and imaging findings to guide evidence-based interventions. Nurses monitor vital signs, provide patient education, and support adherence to hormone replacement regimens. Pharmacists ensure appropriate medication selection, dosing, and monitoring. Coordinated communication among specialists, primary care clinicians, and mental health professionals promotes timely intervention, symptom management, and long-term follow-up. By integrating these strategies, the care team can optimize patient-centered outcomes, enhance safety, and improve overall team performance in managing complex hypothalamic disorders.

References

[1]

Marshall JC, Eagleson CA, McCartney CR. Hypothalamic dysfunction. Molecular and cellular endocrinology. 2001 Oct 25:183(1-2):29-32 [PubMed PMID: 11604221]

Level 3 (low-level) evidence

[2]

Rigas A, Farmakis D, Papingiotis G, Bakosis G, Parissis J. Hypothalamic dysfunction in heart failure: pathogenetic mechanisms and therapeutic implications. Heart failure reviews. 2018 Jan:23(1):55-61. doi: 10.1007/s10741-017-9659-7. Epub [PubMed PMID: 29052045]

[3]

Kopelman MD, Thomson AD, Guerrini I, Marshall EJ. The Korsakoff syndrome: clinical aspects, psychology and treatment. Alcohol and alcoholism (Oxford, Oxfordshire). 2009 Mar-Apr:44(2):148-54. doi: 10.1093/alcalc/agn118. Epub 2009 Jan 16 [PubMed PMID: 19151162]

Level 1 (high-level) evidence

[4]

Wijnia JW. A Clinician's View of Wernicke-Korsakoff Syndrome. Journal of clinical medicine. 2022 Nov 15:11(22):. doi: 10.3390/jcm11226755. Epub 2022 Nov 15 [PubMed PMID: 36431232]

[5]

Cook N, Miller J, Hart J. Parent observed neuro-behavioral and pro-social improvements with oxytocin following surgical resection of craniopharyngioma. Journal of pediatric endocrinology & metabolism : JPEM. 2016 Aug 1:29(8):995-1000. doi: 10.1515/jpem-2015-0445. Epub [PubMed PMID: 27166717]

[6]

Spallone A, Izzo C, Giannone C. Hypothalamic dysfunctions as a late consequence of surgical opening of the lamina terminalis. A controversial hypothesis. Neuro endocrinology letters. 2012:33(6):590-6 [PubMed PMID: 23160226]

Level 3 (low-level) evidence

[7]

de Vetten L, Bocca G. Systemic effects of hypothermia due to hypothalamic dysfunction after resection of a craniopharyngioma: case report and review of literature. Neuropediatrics. 2013 Jun:44(3):159-62. doi: 10.1055/s-0032-1327773. Epub 2012 Oct 9 [PubMed PMID: 23047234]

Level 3 (low-level) evidence

[8]

Krahulik D, Zapletalova J, Frysak Z, Vaverka M. Dysfunction of hypothalamic-hypophysial axis after traumatic brain injury in adults. Journal of neurosurgery. 2010 Sep:113(3):581-4. doi: 10.3171/2009.10.JNS09930. Epub [PubMed PMID: 19929195]

[9]

Tudor RM, Thompson CJ. Posterior pituitary dysfunction following traumatic brain injury: review. Pituitary. 2019 Jun:22(3):296-304. doi: 10.1007/s11102-018-0917-z. Epub [PubMed PMID: 30334138]

[10]

Javed Z, Qamar U, Sathyapalan T. Pituitary and/or hypothalamic dysfunction following moderate to severe traumatic brain injury: Current perspectives. Indian journal of endocrinology and metabolism. 2015 Nov-Dec:19(6):753-63. doi: 10.4103/2230-8210.167561. Epub [PubMed PMID: 26693424]

Level 3 (low-level) evidence

[11]

Puget S, Garnett M, Wray A, Grill J, Habrand JL, Bodaert N, Zerah M, Bezerra M, Renier D, Pierre-Kahn A, Sainte-Rose C. Pediatric craniopharyngiomas: classification and treatment according to the degree of hypothalamic involvement. Journal of neurosurgery. 2007 Jan:106(1 Suppl):3-12 [PubMed PMID: 17233305]

Level 2 (mid-level) evidence

[12]

Feng Y, Ni M, Wang YG, Zhong LY. Comparison of neuroendocrine dysfunction in patients with adamantinomatous and papillary craniopharyngiomas. Experimental and therapeutic medicine. 2019 Jan:17(1):51-56. doi: 10.3892/etm.2018.6953. Epub 2018 Nov 12 [PubMed PMID: 30651764]

[13]

Marcus HJ, Rasul FT, Hussein Z, Baldeweg SE, Spoudeas HA, Hayward R, Jeelani NUO, Thompson D, Grieve JP, Dorward NL, Aquilina K. Craniopharyngioma in children: trends from a third consecutive single-center cohort study. Journal of neurosurgery. Pediatrics. 2020 Mar 1:25(3):242-250. doi: 10.3171/2019.10.PEDS19147. Epub 2019 Dec 20 [PubMed PMID: 31860822]

[14]

Castro-Dufourny I, Carrasco R, Pascual JM. Chordoid glioma: A new paradigm of hypothalamic dysfunction? Pituitary. 2017 Jun:20(3):393-394. doi: 10.1007/s11102-016-0771-9. Epub [PubMed PMID: 27798757]

[15]

Guo Y, Pei L, Li Y, Li C, Gui S, Ni M, Liu P, Zhang Y, Zhong L. Characteristics and factors influencing hypothalamic pituitary dysfunction in patients with craniopharyngioma. Frontiers in endocrinology. 2023:14():1180591. doi: 10.3389/fendo.2023.1180591. Epub 2023 Jun 2 [PubMed PMID: 37324266]

[16]

Bhandare N, Kennedy L, Malyapa RS, Morris CG, Mendenhall WM. Hypopituitarism after radiotherapy for extracranial head and neck cancers. Head & neck. 2008 Sep:30(9):1182-92. doi: 10.1002/hed.20847. Epub [PubMed PMID: 18446838]

Level 2 (mid-level) evidence

[17]

Sfeir JG, Kittah NEN, Tamhane SU, Jasim S, Chemaitilly W, Cohen LE, Murad MH. Diagnosis of GH Deficiency as a Late Effect of Radiotherapy in Survivors of Childhood Cancers. The Journal of clinical endocrinology and metabolism. 2018 Aug 1:103(8):2785-2793. doi: 10.1210/jc.2018-01204. Epub [PubMed PMID: 29982753]

[18]

Rose SR, Schreiber RE, Kearney NS, Lustig RH, Danish RK, Burghen GA, Hudson MM. Hypothalamic dysfunction after chemotherapy. Journal of pediatric endocrinology & metabolism : JPEM. 2004 Jan:17(1):55-66 [PubMed PMID: 14960022]

Level 2 (mid-level) evidence

[19]

van Iersel L, Li Z, Srivastava DK, Brinkman TM, Bjornard KL, Wilson CL, Green DM, Merchant TE, Pui CH, Howell RM, Smith SA, Armstrong GT, Hudson MM, Robison LL, Ness KK, Gajjar A, Krull KR, Sklar CA, van Santen HM, Chemaitilly W. Hypothalamic-Pituitary Disorders in Childhood Cancer Survivors: Prevalence, Risk Factors and Long-Term Health Outcomes. The Journal of clinical endocrinology and metabolism. 2019 Dec 1:104(12):6101-6115. doi: 10.1210/jc.2019-00834. Epub [PubMed PMID: 31373627]

[20]

Chemaitilly W, Armstrong GT, Gajjar A, Hudson MM. Hypothalamic-Pituitary Axis Dysfunction in Survivors of Childhood CNS Tumors: Importance of Systematic Follow-Up and Early Endocrine Consultation. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2016 Dec 20:34(36):4315-4319 [PubMed PMID: 27998231]

Level 1 (high-level) evidence

[21]

Clement SC, Schouten-van Meeteren AY, Boot AM, Claahsen-van der Grinten HL, Granzen B, Sen Han K, Janssens GO, Michiels EM, van Trotsenburg AS, Vandertop WP, van Vuurden DG, Kremer LC, Caron HN, van Santen HM. Prevalence and Risk Factors of Early Endocrine Disorders in Childhood Brain Tumor Survivors: A Nationwide, Multicenter Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2016 Dec 20:34(36):4362-4370 [PubMed PMID: 27998218]

Level 2 (mid-level) evidence

[22]

Kanter NG, Cohen-Woods S, Balfour DA, Burt MG, Waterman AL, Koczwara B. Hypothalamic-Pituitary-Adrenal Axis Dysfunction in People With Cancer: A Systematic Review. Cancer medicine. 2024 Nov:13(22):e70366. doi: 10.1002/cam4.70366. Epub [PubMed PMID: 39569439]

Level 1 (high-level) evidence

[23]

Baskaran C, Misra M, Klibanski A. Effects of Anorexia Nervosa on the Endocrine System. Pediatric endocrinology reviews : PER. 2017 Mar:14(3):302-311. doi: 10.17458/per.vol14.2017.BMK.effectsanorexianervosa. Epub [PubMed PMID: 28508601]

[24]

Sayama T, Inamura T, Matsushima T, Inoha S, Inoue T, Fukui M. High incidence of hyponatremia in patients with ruptured anterior communicating artery aneurysms. Neurological research. 2000 Mar:22(2):151-5 [PubMed PMID: 10763501]

Level 2 (mid-level) evidence

[25]

Nguyen BN, Yablon SA, Chen CY. Hypodipsic hypernatremia and diabetes insipidus following anterior communicating artery aneurysm clipping: diagnostic and therapeutic challenges in the amnestic rehabilitation patient. Brain injury. 2001 Nov:15(11):975-80 [PubMed PMID: 11689095]

Level 3 (low-level) evidence

[26]

Angulo MA, Butler MG, Cataletto ME. Prader-Willi syndrome: a review of clinical, genetic, and endocrine findings. Journal of endocrinological investigation. 2015 Dec:38(12):1249-63. doi: 10.1007/s40618-015-0312-9. Epub 2015 Jun 11 [PubMed PMID: 26062517]

[27]

Alves C, Franco RR. Prader-Willi syndrome: endocrine manifestations and management. Archives of endocrinology and metabolism. 2020 May-Jun:64(3):223-234. doi: 10.20945/2359-3997000000248. Epub [PubMed PMID: 32555988]

[28]

Laitinen EM, Vaaralahti K, Tommiska J, Eklund E, Tervaniemi M, Valanne L, Raivio T. Incidence, phenotypic features and molecular genetics of Kallmann syndrome in Finland. Orphanet journal of rare diseases. 2011 Jun 17:6():41. doi: 10.1186/1750-1172-6-41. Epub 2011 Jun 17 [PubMed PMID: 21682876]

[29]

Maione L, Dwyer AA, Francou B, Guiochon-Mantel A, Binart N, Bouligand J, Young J. GENETICS IN ENDOCRINOLOGY: Genetic counseling for congenital hypogonadotropic hypogonadism and Kallmann syndrome: new challenges in the era of oligogenism and next-generation sequencing. European journal of endocrinology. 2018 Mar:178(3):R55-R80. doi: 10.1530/EJE-17-0749. Epub 2018 Jan 12 [PubMed PMID: 29330225]

[30]

Dhanwal DK, Vyas A, Sharma A, Saxena A. Hypothalamic pituitary abnormalities in tubercular meningitis at the time of diagnosis. Pituitary. 2010 Dec:13(4):304-10. doi: 10.1007/s11102-010-0234-7. Epub [PubMed PMID: 20495961]

[31]

Mohammed H, Goyal MK, Dutta P, Sharma K, Modi M, Shah F, Shree R, Jain A, Jain G, Khandelwal N, Sharma N, Lal V. Hypothalamic and pituitary dysfunction is common in tubercular meningitis: A prospective study from a tertiary care center in Northern India. Journal of the neurological sciences. 2018 Dec 15:395():153-158. doi: 10.1016/j.jns.2018.10.011. Epub 2018 Oct 9 [PubMed PMID: 30321796]

[32]

Burfeind KG, Yadav V, Marks DL. Hypothalamic Dysfunction and Multiple Sclerosis: Implications for Fatigue and Weight Dysregulation. Current neurology and neuroscience reports. 2016 Nov:16(11):98 [PubMed PMID: 27662896]

[33]

Rao R, Dimitriades VR, Weimer M, Sandlin C. Neurosarcoidosis in Pediatric Patients: A Case Report and Review of Isolated and Systemic Neurosarcoidosis. Pediatric neurology. 2016 Oct:63():45-52. doi: 10.1016/j.pediatrneurol.2016.05.018. Epub 2016 Jun 27 [PubMed PMID: 27524272]

Level 3 (low-level) evidence

[34]

Ma GM, Chow JS, Taylor GA. Review of paraneoplastic syndromes in children. Pediatric radiology. 2019 Apr:49(4):534-550. doi: 10.1007/s00247-019-04371-y. Epub 2019 Mar 16 [PubMed PMID: 30877339]

[35]

Graziani A, Casalini P, Mirici-Cappa F, Pezzi G, Giuseppe Stefanini F. Hypoventilation improvement in an adult non-invasively ventilated patient with Rapid-onset Obesity with Hypothalamic Dysfunction Hypoventilation and Autonomic Dysregulation (ROHHAD). Pneumologia (Bucharest, Romania). 2016 Oct-Dec:65(4):222-4 [PubMed PMID: 29543408]

[36]

Al-Harbi AS, Al-Shamrani A, Al-Shawwa BA. Rapid-onset obesity, hypothalamic dysfunction, hypoventilation, and autonomic dysregulation in Saudi Arabia. Saudi medical journal. 2016 Nov:37(11):1258-1260. doi: 10.15537/smj.2016.11.15578. Epub [PubMed PMID: 27761566]

[37]

Meczekalski B, Katulski K, Czyzyk A, Podfigurna-Stopa A, Maciejewska-Jeske M. Functional hypothalamic amenorrhea and its influence on women's health. Journal of endocrinological investigation. 2014 Nov:37(11):1049-56. doi: 10.1007/s40618-014-0169-3. Epub 2014 Sep 9 [PubMed PMID: 25201001]

Level 3 (low-level) evidence

[38]

Ortiz JB, Sukhina A, Balkan B, Harootunian G, Adelson PD, Lewis KS, Oatman O, Subbian V, Rowe RK, Lifshitz J. Epidemiology of Pediatric Traumatic Brain Injury and Hypothalamic-Pituitary Disorders in Arizona. Frontiers in neurology. 2019:10():1410. doi: 10.3389/fneur.2019.01410. Epub 2020 Jan 22 [PubMed PMID: 32038466]

[39]

Ghigo E, Masel B, Aimaretti G, Léon-Carrión J, Casanueva FF, Dominguez-Morales MR, Elovic E, Perrone K, Stalla G, Thompson C, Urban R. Consensus guidelines on screening for hypopituitarism following traumatic brain injury. Brain injury. 2005 Aug 20:19(9):711-24 [PubMed PMID: 16195185]

Level 3 (low-level) evidence

[40]

Aimaretti G, Ambrosio MR, Benvenga S, Borretta G, De Marinis L, De Menis E, Di Somma C, Faustini-Fustini M, Grottoli S, Gasco V, Gasperi M, Logoluso F, Scaroni C, Giordano G, Ghigo E, Italian Society of Endocrinology. Hypopituitarism and growth hormone deficiency (GHD) after traumatic brain injury (TBI). Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society. 2004 Jun:14 Suppl A():S114-7 [PubMed PMID: 15135791]

[41]

Popovic V. GH deficiency as the most common pituitary defect after TBI: clinical implications. Pituitary. 2005:8(3-4):239-43 [PubMed PMID: 16508711]

[42]

Bhusal A, Rahman MH, Suk K. Hypothalamic inflammation in metabolic disorders and aging. Cellular and molecular life sciences : CMLS. 2021 Dec 15:79(1):32. doi: 10.1007/s00018-021-04019-x. Epub 2021 Dec 15 [PubMed PMID: 34910246]

[43]

Müller HL, Tauber M, Lawson EA, Özyurt J, Bison B, Martinez-Barbera JP, Puget S, Merchant TE, van Santen HM. Hypothalamic syndrome. Nature reviews. Disease primers. 2022 Apr 21:8(1):24. doi: 10.1038/s41572-022-00351-z. Epub 2022 Apr 21 [PubMed PMID: 35449162]

[44]

Spindler M, Palombo M, Zhang H, Thiel CM. Dysfunction of the hypothalamic-pituitary adrenal axis and its influence on aging: the role of the hypothalamus. Scientific reports. 2023 Apr 27:13(1):6866. doi: 10.1038/s41598-023-33922-5. Epub 2023 Apr 27 [PubMed PMID: 37105986]

[45]

van Santen HM, Müller HL. Management of Acquired Hypothalamic Dysfunction and the Hypothalamic Syndrome; It Is More Than Obesity. Endocrine reviews. 2025 Nov 24:46(6):891-907. doi: 10.1210/endrev/bnaf025. Epub [PubMed PMID: 40746184]

[46]

van Santen HM, van Schaik J, van Roessel IMAA, Beckhaus J, Boekhoff S, Müller HL. Diagnostic criteria for the hypothalamic syndrome in childhood. European journal of endocrinology. 2023 Feb 14:188(2):. pii: lvad009. doi: 10.1093/ejendo/lvad009. Epub [PubMed PMID: 36737045]

[47]

Della Guardia L, Codella R. Exercise Restores Hypothalamic Health in Obesity by Reshaping the Inflammatory Network. Antioxidants (Basel, Switzerland). 2023 Jan 28:12(2):. doi: 10.3390/antiox12020297. Epub 2023 Jan 28 [PubMed PMID: 36829858]